EXHIBIT 1.1 Transkaryotic Therapies, Inc. 1.25% Convertible Senior Notes due May 15, 2011 Underwriting AgreementTranskaryotic Therapies Inc • April 29th, 2004 • Biological products, (no disgnostic substances) • New York
Company FiledApril 29th, 2004 Industry Jurisdiction